DEPLOYDatabase

Person

Sameer Sheth

Co-founder of Motif Neurotech, a Houston-based therapeutic brain-computer interface company developing the Motif XCS System for treatment-resistant depression. A neurosurgeon and neuroscientist specializing in movement disorders, epilepsy, and psychiatric neurosurgery, he earned his MD and PhD through UCLA's Medical Scientist Training Program and completed his neurosurgical residency at Massachusetts General Hospital and Harvard Medical School. He is also a professor of neurosurgery and directs the Gordon and Mary Cain Pediatric Neurology Research Laboratories.

American · 1 current role · 1 founding

Track Sameer Sheth

Physical AI footprint (1)

The physical AI companies Sameer is connected to that DEPLOY verifies. The full record is one click away.

  • Motif Neurotechverified→
    Founder

    Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression.

    Series A · $19M1 model

Current roles (1)

Foundings (1)

See all founders in the registry.

Co-founders (1)

Sources (2)

  1. https://www.businesswire.com/news/home/20260427361988/en/Motif-Neurotech-Receives-FDA-Approval-to-Begin-First-Clinical-Trial-of-its-Therapeutic-BCI-for-Treatment-Resistant-Depression
  2. https://motifneuro.tech/company

Mentioned on (1)

Registry pages whose text names Sameer Sheth.

Deploy Watch

Track Sameer Sheth on Deploy.

We notify you when a verified role changes, a founded-company event lands, or litigation surfaces.